Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 4
2004 3
2005 3
2006 8
2007 6
2008 6
2009 8
2010 4
2011 6
2012 16
2013 7
2014 15
2015 25
2016 15
2017 22
2018 12
2019 14
2020 12
2021 16
2022 13
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ. Donker M, et al. Among authors: petignat p. Lancet Oncol. 2014 Nov;15(12):1303-10. doi: 10.1016/S1470-2045(14)70460-7. Epub 2014 Oct 15. Lancet Oncol. 2014. PMID: 25439688 Free PMC article. Clinical Trial.
Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial.
Bartels SAL, Donker M, Poncet C, Sauvé N, Straver ME, van de Velde CJH, Mansel RE, Blanken C, Orzalesi L, Klinkenbijl JHG, van der Mijle HCJ, Nieuwenhuijzen GAP, Veltkamp SC, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JWS, Belkacemi Y, Petignat P, Schinagl DAX, Coens C, van Tienhoven G, van Duijnhoven F, Rutgers EJT. Bartels SAL, et al. Among authors: petignat p. J Clin Oncol. 2023 Apr 20;41(12):2159-2165. doi: 10.1200/JCO.22.01565. Epub 2022 Nov 16. J Clin Oncol. 2023. PMID: 36383926 Clinical Trial.
Médecine hautement spécialisée et gynécologie.
Mathevet P, Petignat P. Mathevet P, et al. Among authors: petignat p. Rev Med Suisse. 2022 Oct 19;18(800):1939. doi: 10.53738/REVMED.2022.18.800.1939. Rev Med Suisse. 2022. PMID: 36259698 French. No abstract available.
Adenomyosis and Endometrial Cancer: Literature Review.
Habiba M, Pluchino N, Petignat P, Bianchi P, Brosens IA, Benagiano G. Habiba M, et al. Among authors: petignat p. Gynecol Obstet Invest. 2018;83(4):313-328. doi: 10.1159/000487320. Epub 2018 Jun 6. Gynecol Obstet Invest. 2018. PMID: 29874641 Review.
Endometriosis-Associated Abdominal Wall Cancer: A Poor Prognosis?
Taburiaux L, Pluchino N, Petignat P, Wenger JM. Taburiaux L, et al. Among authors: petignat p. Int J Gynecol Cancer. 2015 Nov;25(9):1633-8. doi: 10.1097/IGC.0000000000000556. Int J Gynecol Cancer. 2015. PMID: 26448542 Review.
Hormonal causes of recurrent pregnancy loss (RPL).
Pluchino N, Drakopoulos P, Wenger JM, Petignat P, Streuli I, Genazzani AR. Pluchino N, et al. Among authors: petignat p. Hormones (Athens). 2014 Jul-Sep;13(3):314-22. doi: 10.14310/horm.2002.1505. Hormones (Athens). 2014. PMID: 25079455 Free article. Review.
210 results